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Materials and Methods

Reagents
During coating, the separated lower parts of the tubes were filled with the SP1-antibody diluted 10 000-fold with sodium carbonate buffer (10 mmol/L, pH 9.2). The upper cylindrical parts were partly immersed in hPL-antiserum diluted 400-fold with the samebuffer. The part of the inner wall of the upper tube exposed to reagents when finally positioned corresponded to a volume of 1 mL. The components were incubated for 16 h at 4 #{176}C with the antisera dilutions. After removal of the coating solutions, the tubes were washed once with distilled water, once with the radioimmunoassay buffer (see below) and then twice more with distilled water. The lower part was then inserted into the upper part to a constant depth.
Radioimmunoassay Procedure
To 2 mL of the radioimmunoassay buffer (20 mmol/L sodium phosphate buffer, pH 7.4, containing, per liter, 10 g of bovine serum albumin and 1 g of NaN3) add 10 L of pregnancy serum. Pipette 200 zL of serum diluted in buffer into the multi-RIA-tube, and add 2 mL of the tracer mixture containing approximately 80000 cpm of [1251]hPL and 80 000 cpm of [imI]SP1. Incubate for 16 hat room temperature, then aspirate the contents, wash each tube with 2 mL and then with 4 mL of tap water, detach the two components of the tube, place them separately into disposable tubes, and count the radioactivity for 2 mm in a multi-detector gamma counter (1260 Multigamma; LKB/Wallac, Turku, Finland).
Each unknown sample was assayed in duplicate. Every series of assays included duplicate hPL and SP1 standards with the following concentrations of the compound to be measured: hPL, 0, 10, 20,40,60,80, and 120 igfL; SP1, 0, 125, 250, 500, 1000,2000, and 4000 zg/L. The concentrations of hPL and SP1 in the sera were calculated on the basis of standard curves generated from these standards. plotted vs serum dilutions (Figure 3 ). The nonspecific binding in both assays was less than 1% of the total counts. Known amounts of hPL (corresponding to 2,4,8, 12,16, and 24 mgfL) and 5P1 (corresponding to 25,50,100,200,400, and 800 mg/L) were added to a pool of male serum and assayed. Analytical recoveries of 95-115% for hPL and of 94-130% for SP were obtained. Within-assay coefficients of variation were 9.1 and 10.7% for hPL and SP1, respectively, and the corresponding figures for between-assay variation were 12.0-13.7% and 9.7-18.3% (Table 1) .
We compared results by the present technique for hPL measurement with those by a liquid-phase radioimmunoassay involving polyethylene glycol separation (2). As indicated in Table 2 , they were very similar.
Discussion
When we applied this novel principle for the simultaneous radioimmunoassay of two components in a single sample by use of a specially designed vessel to the determination of hPL and SP1 in pregnancy serum, the accuracy and precision for the two measurements were similar to those obtained for radioimmunoassays of proteins in general. Specifically, in the case of hPL, the results obtained with the present technique were very similar to those measured by liquid-phase radioimmunoassay. The receptacles used were handmade and it is very likely that increased standardization of the manufacturing of the tubes would add additional precision to the measurements. The essence of our technique is that the receptacle used consists of detachably connected parts carrying different antibodies. With use of appropriate receptacles and tracers, several substances probably can be determined in a single sample contained in one receptacle. Combined with the use of efficient sample processors and multi-detector counting devices, this approach may lead to increased laboratory efficiency. The general idea described can be extended in relation to the structure of the receptacle, the reagent immobilized, and the type of signal measured.
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